{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:39:04Z","timestamp":1792723144083,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"DOI":"10.1186\/s13011-026-00751-4","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:16:54Z","timestamp":1785165414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment interventions for co-occurring opioid use disorder, and sleep disturbances: a scoping review"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0361-0985","authenticated-orcid":false,"given":"Elisabeth","family":"Ruppert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Rolling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Medde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury","family":"Durpoix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lalanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"10208","key":"751_CR1","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","volume":"394","author":"L Degenhardt","year":"2019","unstructured":"Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394(10208):1560\u201379. https:\/\/doi.org\/10.1016\/S0140-6736(19)32229-9. PubMed PMID: 31657732; PubMed Central PMCID: PMC7068135.","journal-title":"Lancet"},{"key":"751_CR2","volume-title":"statistical manual of mental disorders: DSM-5","author":"Diagnostic","year":"2013","unstructured":"Diagnostic. and statistical manual of mental disorders: DSM-5. 5th ed. Washington: American psychiatric association; 2013.","edition":"5"},{"key":"751_CR3","doi-asserted-by":"publisher","first-page":"109551","DOI":"10.1016\/j.drugalcdep.2022.109551","volume":"238","author":"T Santo","year":"2022","unstructured":"Santo T, Campbell G, Gisev N, Martino-Burke D, Wilson J, Colledge-Frisby S, et al. Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis. Drug Alcohol Depend. 2022;238:109551. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109551. PubMed PMID: 35797876.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"751_CR4","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/AJP.0000000000000603","volume":"34","author":"MD Sullivan","year":"2018","unstructured":"Sullivan MD. Depression Effects on Long-term Prescription Opioid Use, Abuse, and Addiction. Clin J Pain. 2018;34(9):878\u201384. 10. 1097\/AJP.0000000000000603 PubMed PMID: 29505419.","journal-title":"Clin J Pain"},{"issue":"17","key":"751_CR5","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMp1801417","volume":"378","author":"MA Oquendo","year":"2018","unstructured":"Oquendo MA, Volkow ND, Suicide. A Silent Contributor to Opioid-Overdose Deaths. N Engl J Med. 2018;378(17):1567\u20139. https:\/\/doi.org\/10.1056\/NEJMp1801417. PubMed PMID: 29694805.","journal-title":"N Engl J Med"},{"issue":"2","key":"751_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4088\/jcp.v67n0211","volume":"67","author":"KP Conway","year":"2006","unstructured":"Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67(2):247\u201357. https:\/\/doi.org\/10.4088\/jcp.v67n0211. PubMed PMID: 16566620.","journal-title":"J Clin Psychiatry"},{"key":"751_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.copsyc","volume":"30","author":"KJ Langdon","year":"2019","unstructured":"Langdon KJ, Dove K, Ramsey S. Comorbidity of opioid-related and anxiety-related symptoms and disorders. Curr Opin Psychol. 2019;30:17\u201323. https:\/\/doi.org\/10.1016\/j.copsyc. 2018.12.020 PubMed PMID: 30711906; PubMed Central PMCID: PMC6609499.","journal-title":"Curr Opin Psychol"},{"issue":"7","key":"751_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.brat.2008.03.010","volume":"46","author":"CW Lejuez","year":"2008","unstructured":"Lejuez CW, Zvolensky MJ, Daughters SB, Bornovalova MA, Paulson A, Tull MT, et al. Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack\/cocaine users in residential substance use treatment. Behav Res Ther. 2008;46(7):811\u20138. https:\/\/doi.org\/10.1016\/j.brat.2008.03.010. PubMed PMID: 18466878; PubMed Central PMCID: PMC3175736.","journal-title":"Behav Res Ther"},{"key":"751_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.drugalcdep.2017.10.023","volume":"183","author":"BA Bouvier","year":"2018","unstructured":"Bouvier BA, Waye KM, Elston B, Hadland SE, Green TC, Marshall BDL. Prevalence and correlates of benzodiazepine use and misuse among young adults who use prescription opioids non-medically. Drug Alcohol Depend. 2018;183:73\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.10.023. PubMed PMID: 29241103; PubMed Central PMCID: PMC5803376.","journal-title":"Drug Alcohol Depend"},{"key":"751_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.psychres.2016.04.064","volume":"245","author":"E Karsinti","year":"2016","unstructured":"Karsinti E, Fortias M, Dupuy G, Ksouda K, Laqueille X, Simonpoli AM, et al. Anxiety disorders are associated with early onset of heroin use and rapid transition to dependence in methadone maintained patients. Psychiatry Res. 2016;245:423\u20136. https:\/\/doi.org\/10.1016\/j.psychres.2016.04.064. PubMed PMID: 27620325.","journal-title":"Psychiatry Res"},{"key":"751_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jsat.2015.06.001","volume":"58","author":"B Larance","year":"2015","unstructured":"Larance B, Lintzeris N, Bruno R, Peacock A, Cama E, Ali R, et al. The characteristics of a cohort who tamper with prescribed and diverted opioid medications. J Subst Abuse Treat. 2015;58:51\u201361. 06.001 PubMed PMID: 26286818.","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"751_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jama.2012.234","volume":"307","author":"KH Seal","year":"2012","unstructured":"Seal KH, Shi Y, Cohen G, Cohen BE, Maguen S, Krebs EE, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307(9):940\u20137. https:\/\/doi.org\/10.1001\/jama.2012.234. PubMed PMID: 22396516.","journal-title":"JAMA"},{"issue":"1","key":"751_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/08897077.2019.1621238","volume":"41","author":"V Hruschak","year":"2020","unstructured":"Hruschak V, Hildenbrand AK, Cochran G. Psychiatric comorbidity and co-occurring opioid misuse: Depression mediates the relationship between post-traumatic stress disorder and opioid misuse in community pharmacy settings. Subst Abus. 2020;41(1):77\u201384. https:\/\/doi.org\/10.1080\/08897077.2019.1621238. PubMed PMID: 31638877.","journal-title":"Subst Abus"},{"issue":"4","key":"751_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1124\/mol.119.119107","volume":"98","author":"D Eacret","year":"2020","unstructured":"Eacret D, Veasey SC, Blendy JA. Bidirectional Relationship between Opioids and Disrupted Sleep: Putative Mechanisms. Mol Pharmacol. 2020;98(4):445\u201353. https:\/\/doi.org\/10.1124\/mol.119.119107.","journal-title":"Mol Pharmacol"},{"issue":"4","key":"751_CR15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.mcna.2018.02.012","volume":"102","author":"S Chakravorty","year":"2018","unstructured":"Chakravorty S, Vandrey RG, He S, Stein MD. Sleep Management Among Patients with Substance Use Disorders. Med Clin North Am. 2018;102(4):733\u201343. https:\/\/doi.org\/10.1016\/j.mcna.2018.02.012. PubMed PMID: 29933826; PubMed Central PMCID: PMC6289280.","journal-title":"Med Clin North Am"},{"key":"751_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.sleep.2021.05.021","volume":"84","author":"AK Wilkerson","year":"2021","unstructured":"Wilkerson AK, McRae-Clark AL. A review of sleep disturbance in adults prescribed medications for opioid use disorder: potential treatment targets for a highly prevalent, chronic problem. Sleep Med. 2021;84:142\u201353. https:\/\/doi.org\/10.1016\/j.sleep.2021.05.021.","journal-title":"Sleep Med"},{"issue":"1","key":"751_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13722-016-0056-7","volume":"11","author":"GA Angarita","year":"2016","unstructured":"Angarita GA, Emadi N, Hodges S, Morgan PT. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict Sci Clin Pract. 2016;11(1):9. https:\/\/doi.org\/10.1186\/s13722-016-0056-7.","journal-title":"Addict Sci Clin Pract"},{"key":"751_CR18","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"751_CR19","first-page":"359","volume":"2006","author":"X Huang","year":"2006","unstructured":"Huang X, Lin J, Demner-Fushman D. Evaluation of PICO as a knowledge representation for clinical questions. AMIA Annu Symp Proc. 2006;2006:359\u201363. PubMed PMID: 17238363; PubMed Central PMCID: PMC1839740.","journal-title":"AMIA Annu Symp Proc"},{"issue":"3","key":"751_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-0447.1998.tb","volume":"97","author":"M Srisurapanont","year":"1998","unstructured":"Srisurapanont M, Jarusuraisin N. Amitriptyline vs. lorazepam in the treatment of opiate-withdrawal insomnia: a randomized double-blind study. Acta Psychiatr Scand. 1998;97(3):233\u20135. https:\/\/doi.org\/10.1111\/j.1600-0447.1998.tb. 09993.x PubMed PMID: 9543313.","journal-title":"Acta Psychiatr Scand"},{"issue":"21","key":"751_CR21","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.lfs.2005.05.036","volume":"77","author":"L Stella","year":"2005","unstructured":"Stella L, D\u2019Ambra C, Mazzeo F, Capuano A, Del Franco F, Avolio A, et al. Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients. Life Sci. 2005;77(21):2717\u201322. https:\/\/doi.org\/10.1016\/j.lfs.2005.05.036. PubMed PMID: 15979652.","journal-title":"Life Sci"},{"issue":"1","key":"751_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/10550880903438925","volume":"29","author":"M Hillhouse","year":"2010","unstructured":"Hillhouse M, Domier CP, Chim D, Ling W. Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomes. J Addict Dis. 2010;29(1):23\u20139. https:\/\/doi.org\/10.1080\/10550880903438925. PubMed PMID: 20390696; PubMed Central PMCID: PMC2856108.","journal-title":"J Addict Dis"},{"issue":"1","key":"751_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/00952990.2010.540281","volume":"37","author":"DJ Mysels","year":"2011","unstructured":"Mysels DJ, Cheng WY, Nunes EV, Sullivan MA. The association between naltrexone treatment and symptoms of depression in opioid-dependent patients. Am J Drug Alcohol Abuse. 2011;37(1):22\u20136. https:\/\/doi.org\/10.3109\/00952990.2010.540281. PubMed PMID: 21192125; PubMed Central PMCID: PMC3111044.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"751_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11596-012-0073-z","volume":"32","author":"D Chen","year":"2012","unstructured":"Chen D, Liu Y, He W, Wang H, Wang Z. Neurotransmitter-precursor-supplement intervention for detoxified heroin addicts. J Huazhong Univ Sci Technolog Med Sci. 2012;32(3):422\u20137. https:\/\/doi.org\/10.1007\/s11596-012-0073-z. PubMed PMID: 22684569.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"3","key":"751_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.drugalcdep.2013.04.021","volume":"132","author":"E Krupitsky","year":"2013","unstructured":"Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Tsoy M, Wahlgren V, et al. Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia. Drug Alcohol Depend. 2013;132(3):674\u201380.https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.04.021. PubMed PMID: 23683793; PubMed Central PMCID: PMC3971535.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"751_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.drugalcdep.2013.05.010","volume":"133","author":"MR Lofwall","year":"2013","unstructured":"Lofwall MR, Babalonis S, Nuzzo PA, Siegel A, Campbell C, Walsh SL. Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial. Drug Alcohol Depend. 2013;133(1):188\u201397. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.05.010. PubMed PMID: 23755929; PubMed Central PMCID: PMC3786049.","journal-title":"Drug Alcohol Depend"},{"key":"751_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.drugalcdep.2015.05.013","volume":"154","author":"A Bisaga","year":"2015","unstructured":"Bisaga A, Sullivan MA, Glass A, Mishlen K, Pavlicova M, Haney M, et al. The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone. Drug Alcohol Depend. 2015;154:38\u201345. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.05.013. PubMed PMID: 26187456; PubMed Central PMCID: PMC4536087.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"751_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4172\/2155-6105.1000354","volume":"9","author":"L Lander","year":"2018","unstructured":"Lander L, Chiasson-Downs K, Andrew M, Rader G, Dohar S, Waibogha K. Yoga as an Adjunctive Intervention to Medication-Assisted Treatment with Buprenorphine+Naloxone. J Addict Res Ther. 2018;9(1):354. https:\/\/doi.org\/10.4172\/2155-6105.1000354. PubMed PMID: 30820364; PubMed Central PMCID: PMC6390289.","journal-title":"J Addict Res Ther"},{"issue":"3","key":"751_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jts.22291","volume":"31","author":"KR Peck","year":"2018","unstructured":"Peck KR, Schumacher JA, Stasiewicz PR, Coffey SF. Adults with Comorbid Posttraumatic Stress Disorder, Alcohol Use Disorder, and Opioid Use Disorder: The Effectiveness of Modified Prolonged Exposure. J Trauma Stress. 2018;31(3):373\u201382. https:\/\/doi.org\/10.1002\/jts.22291. PubMed PMID: 29786898; PubMed Central PMCID: PMC6097633.","journal-title":"J Trauma Stress"},{"issue":"2","key":"751_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/jamapsychiatry.2018.3537","volume":"76","author":"ZeH Latif","year":"2019","unstructured":"Latif ZeH, \u0160altyte Benth J, Solli KK, Opheim A, Kunoe N, Krajci P, et al. Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study. JAMA Psychiatry. 2019;76(2):127. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.3537.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"751_CR31","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1186\/s12888-023-05413-4","volume":"23","author":"SMA Alavi","year":"2023","unstructured":"Alavi SMA, Irani RD, Fattahi P, Pakseresht S. Effects of brief cognitive behavioral therapy on mental health in substance-related disorder: a randomized controlled trial. BMC Psychiatry. 2023;23(1):924. https:\/\/doi.org\/10.1186\/s12888-023-05413-4. PubMed PMID: 38066514; PubMed Central PMCID: PMC10709952.","journal-title":"BMC Psychiatry"},{"issue":"7","key":"751_CR32","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/add.16171","volume":"118","author":"J Neale","year":"2023","unstructured":"Neale J, Parkin S, Strang J. How do patients feel during the first 72\u00a0h after initiating long-acting injectable buprenorphine? An embodied qualitative analysis. Addiction. 2023;118(7):1329\u201339. https:\/\/doi.org\/10.1111\/add.16171. PubMed PMID: 36808168.","journal-title":"Addiction"},{"key":"751_CR33","doi-asserted-by":"publisher","first-page":"1273587","DOI":"10.3389\/fpsyt.2023.1273587","volume":"14","author":"S Omidvar Tehrani","year":"2023","unstructured":"Omidvar Tehrani S, Rezaei Ardani A, Akhlaghi S, Shayesteh Zarrin M, Talaei A. Long-term detoxification of opioid use disorder with opium tincture assisted treatment. Front Psychiatry. 2023;14:1273587. https:\/\/doi.org\/10.3389\/fpsyt.2023.1273587. PubMed PMID: 38144477; PubMed Central PMCID: PMC10748504.","journal-title":"Front Psychiatry"},{"issue":"4","key":"751_CR34","doi-asserted-by":"publisher","first-page":"zsae025","DOI":"10.1093\/sleep\/zsae025","volume":"47","author":"MJ Reid","year":"2024","unstructured":"Reid MJ, Dunn KE, Abraham L, Ellis J, Hunt C, Gamaldo CE, et al. Suvorexant alters dynamics of the sleep-electroencephalography-power spectrum and depressive-symptom trajectories during inpatient opioid withdrawal. Sleep. 2024;47(4):zsae025. https:\/\/doi.org\/10.1093\/sleep\/zsae025. PubMed PMID: 38287879; PubMed Central PMCID: PMC11009034.","journal-title":"Sleep"},{"issue":"2","key":"751_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005","volume":"82","author":"E Peles","year":"2006","unstructured":"Peles E, Schreiber S, Adelson M. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend. 2006;82(2):103\u201310. https:\/\/doi.org\/10.1016\/j.drugalcdep.2005. 08.011 PubMed PMID: 16154297.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"751_CR36","first-page":"1009","volume":"3","author":"WH Zheng","year":"2016","unstructured":"Zheng WH, Wakim RJ, Geary RC, Lander LR, Wen SJ, Xiao MC, et al. Self-reported Sleep Improvement in Buprenorphine MAT (Medication Assisted Treatment) Population. Austin J Drug Abuse Addict. 2016;3(1):1009. PubMed PMID: 28133635; PubMed Central PMCID: PMC5270620.","journal-title":"Austin J Drug Abuse Addict"},{"issue":"3","key":"751_CR37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0740-5472(","volume":"26","author":"MD Stein","year":"2004","unstructured":"Stein MD, Herman DS, Bishop S, Lassor JA, Weinstock M, Anthony J, et al. Sleep disturbances among methadone maintained patients. J Subst Abuse Treat. 2004;26(3):175\u201380. https:\/\/doi.org\/10.1016\/S0740-5472(. 03)00191-0 PubMed PMID: 15063910.","journal-title":"J Subst Abuse Treat"},{"issue":"10","key":"751_CR38","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1080\/10826084.2018.1552298","volume":"54","author":"R Hallinan","year":"2019","unstructured":"Hallinan R, Elsayed M, Espinoza D, Veillard AS, Morley KC, Lintzeris N, et al. Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment. Subst Use Misuse. 2019;54(10):1589\u201398. https:\/\/doi.org\/10.1080\/10826084.2018.1552298. PubMed PMID: 31131668.","journal-title":"Subst Use Misuse"},{"issue":"22","key":"751_CR39","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.3390\/ijerph16224315","volume":"16","author":"TA Le","year":"2019","unstructured":"Le TA, Dang AD, Tran AHT, Nguyen LH, Nguyen THT, Phan HT, et al. Factors Associated with Sleep Disorders among Methadone-Maintained Drug Users in Vietnam. Int J Environ Res Public Health. 2019;16(22):4315. https:\/\/doi.org\/10.3390\/ijerph16224315. PubMed PMID: 31698771; PubMed Central PMCID: PMC6887969.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"751_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7326\/M14-2841","volume":"163","author":"JM Trauer","year":"2015","unstructured":"Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Ann Intern Med. 2015;163(3):191\u2013204. https:\/\/doi.org\/10.7326\/M14-2841. PubMed PMID: 26054060.","journal-title":"Ann Intern Med"},{"issue":"4","key":"751_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.brat","volume":"48","author":"DC Dolan","year":"2010","unstructured":"Dolan DC, Taylor DJ, Bramoweth AD, Rosenthal LD. Cognitive-behavioral therapy of insomnia: a clinical case series study of patients with co-morbid disorders and using hypnotic medications. Behav Res Ther. 2010;48(4):321\u20137. https:\/\/doi.org\/10.1016\/j.brat.2009.12.004. PubMed PMID: 20074701.","journal-title":"Behav Res Ther"},{"issue":"10","key":"751_CR42","doi-asserted-by":"publisher","first-page":"e093358","DOI":"10.1136\/bmjopen-2024-093358","volume":"15","author":"L Lalanne","year":"2025","unstructured":"Lalanne L, Lutz PE, Caparros-Roissard A, Ruppert E, Waeckerle G, Scherer C, et al. Integrative exploration of bio-psycho-social determinants of DSM-5 severity levels of opioid use disorder: the BEBOP cohort study protocol. BMJ Open. 2025;15(10):e093358. https:\/\/doi.org\/10.1136\/bmjopen-2024-093358. PubMed PMID: 41083308; PubMed Central PMCID: PMC12519706.","journal-title":"BMJ Open"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-026-00751-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-026-00751-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-026-00751-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:06:50Z","timestamp":1792721210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-026-00751-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["751"],"URL":"https:\/\/doi.org\/10.1186\/s13011-026-00751-4","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"68"}}